Pathology Analysis Articles & Analysis
5 news found
Data from award-winning presentation at IDWeek 2021 represents the first time Ferring is showcasing the RBX2660 clinical development program as a whole, comprising the largest, most robust program ever conducted in the field of microbiome-based therapeutics for recurrent C. difficile infection (rCDI) Only gut microbiome research program with five clinical studies demonstrating consistent ...
About DiamiR DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient stratification, as well as disease progression and treatment monitoring. ...
ByDiamiR
The patent covers the use of methods developed by DiamiR based on targeted quantitative analysis of microRNAs enriched in the brain and detectable in blood plasma as biomarkers of brain aging. ...
ByDiamiR
"AD is proving to be an extremely difficult indication to develop treatment for due to its heterogeneity and not well understood causes of the pathology associated with the disease. Accurate, minimally-invasive biomarkers reflective of underlying pathophysiological processes are urgently needed," said Samuil Umansky, MD, PhD, CSO of DiamiR and Principal Investigator on the ...
ByDiamiR
Even then diagnosis is difficult and the symptoms are often general and can be mistaken for other pathologies. Breath gas analysis is a non-invasive method to collect information on the state of an individual by monitoring the concentration of the volatile organic compounds (VOCs) present in the exhaled breath, which are directly correlate to their ...